Position history for BNP PARIBAS FINANCIAL MARKETS's holdings in Allogene Therapeutics, Inc.
BNP PARIBAS FINANCIAL MARKETS holds 900,424 shares of ALLO (Allogene Therapeutics, Inc.), worth $1.2M as of 2025-Q4. The position was increased (++0.7% shares). ALLO represents 0.0% of BNP PARIBAS FINANCIAL MARKETS's portfolio.
Current Value
$1.2M
Current Shares
900,424
Total Value Change
+$966,186
Total Shares Change
+840,604
Other major holders of ALLO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 900,424 |
+0.7% |
| $1.2M |
| 0.0% |
| $1.31 |
25 |
| 2025-Q3 | Increased | 894,314 | +1.7% | $1.1M | 0.0% | $1.27 | 26 |
| 2025-Q2 | Increased | 878,987 | +0.8% | $993,255 | 0.0% | $1.18 | 25 |
| 2025-Q1 | Increased | 871,597 | +2.6% | $1.3M | 0.0% | $1.55 | 26 |
| 2024-Q4 | Increased | 849,658 | +1732.2% | $1.8M | 0.0% | $2.10 | 42 |
| 2024-Q3 | Increased | 46,374 | +541.5% | $129,847 | 0.0% | $2.91 | 36 |
| 2024-Q2 | Decreased | 7,229 | -87.9% | $16,844 | 0.0% | $2.33 | 0 |
| 2024-Q1 | Decreased | 59,820 | -51.6% | $267,395 | 0.0% | $4.47 | 0 |